Journal Home
Search for

Articles in Press

Return to articles in press list

The effect of under-treatment of breast cancer in women 80 years of age and older

Barbara L. Van LeeuwenaCorresponding Author Informationemail address, K.M. Rosenkranzb1email address, L. Lei Fengc2, I. Bedrosianc2, K. Hartmannc2, K.K. Huntc2, H.M. Kuererc2, M. Rossc2, S.E. Singletaryc2, Gildy V. Babierac2email address, the Department of Surgical Oncology, MD Anderson Cancer Center3

Accepted 27 May 2010. published online 26 July 2010.
Corrected Proof

Abstract 

Background

Several authors have demonstrated a trend toward the under-treatment of elderly and very elderly women with breast cancer. This study was undertaken to determine the impact of under-treatment of breast cancer in women age 80 and older.

Methods

A retrospective chart review of all patients 80 years and older with a newly diagnosed breast cancer at the MD Anderson Cancer Center, Houston, TX, between September 1, 1989 and September 1, 2004 was performed. Data extracted from charts included patient demographics, comorbidity, treatments recommended, treatments received, complications of therapy, disease recurrence and disease related death. Treatments undertaken were analyzed in the context of accepted therapy at the time of diagnosis.

Results

Two hundred twelve patients were identified. The median age was 83.5 years (range 80–97). Overall survival in the entire cohort was 7.28 years with a median follow up of 4 years for patients still alive at the end of the study period. Fifty seven percent of patients were under-treated according to institutional and national guidelines. Women who underwent hormonal therapy only demonstrated decreased disease specific survival (P<0.001 respectively) compared with patients who received multi-modality therapy. Women who underwent partial mastectomy without radiation treatment experienced a significant increase in local regional recurrence (P=0.045). There was an association of increased disease specific survival in patients who had surgical lymph node evaluation compared to those who did not (P=0.04).

Conclusions

Outcomes are compromised in very elderly women with breast cancer in whom less than complete combined modality treatment is undertaken. With the previously demonstrated safety of radiation therapy, hormonal therapy and surgery in the very elderly population, multi-modality therapy should not be routinely withheld in patients in this age category.

a University Medical Center Groningen, Department of Surgery, Hanzeplein 1, 9700 RB Groningen, The Netherlands

b 1 Medical Center Drive, Lebanon, NH 03756, United States

c MD Anderson Cancer Center, Department of Surgical Oncology, 1515 Holcombe Blvd. Unit 444, Houston, TX 77030, United States

Corresponding Author InformationCorresponding author. Tel.: +31 503612317.

1 Tel.: +1 603 650 9479; fax: +1 603 650 8030.

2 Tel.: +1 713 7451563; fax: +1 713 4044572.

3 The Department of Surgical Oncology, MD Anderson Cancer Center includes Feig B, Ames F, Hwang R, Lucci A and Meric-Bernstam F.

PII: S1040-8428(10)00146-0

doi:10.1016/j.critrevonc.2010.05.010